Diabetes

Credit: Sehat Kahani

By Leontina Postelnicu 09:43 am March 13, 2020
A nation of over 200 million citizens, Pakistan is a major player in South Asia, with a large population to care for. Like many countries around the world, it is struggling to address the shortage of doctors and prevalence of chronic diseases while ensuring access to affordable medicine. But where there are challenges, there is also room for innovation. Today, we are seeing entrepreneurs and...
By Dave Muoio 04:06 pm March 12, 2020
Together in perfect harmony. Dexcom and Welldoc have kicked off a new collaboration that will provide Dexcom G6 continuous glucose monitor users with data-analysis insights from Welldoc's digital diabetes management product, BlueStar. These insights include information on how lifestyle factors such as activity, nutrition, sleep and medication adherence are affecting a user's glucose levels. “Now...
By Dave Muoio 02:26 pm March 3, 2020
It was another strong quarter for the ever-growing Livongo Health, which yesterday reported to investors a 137% rise in year-over-year Q4 revenue from $21.2 million to $50.2 million. Full-year revenues followed a similar path, growing 149% from $68.4 million in 2018 to $169.9 million in 2019. “Livongo finished the year with excellent momentum, exceeding all of our guidance metrics, achieving...
By Dave Muoio 03:22 pm February 26, 2020
Type 2 diabetes patients who received a continuous glucose monitoring (CGM) system as part of a virtual diabetes clinic program improved their HbA1c and near-uniformly said they were comfortable self-inserting a sensor with guidance from a remote coach, according to study data presented by Onduo at an academic conference last weekend. Further, while more than half of the study’s nearly 600...
By Laura Lovett 02:13 pm January 13, 2020
Dexcom’s G6 Continuous Glucose Monitoring system will soon be integrated with Livongo’s platform, thanks to a new partnership between the two diabetes-focused companies.  G6 users who are also Livongo members will be able to sync their device to the Livongo platform, which will be able to give users insights and health nudges about their behavior based on the CGM reading. The system will also be...
By Jonah Comstock 11:33 am December 17, 2019
Dublin-based medical technology company Medtronic has acquired digital health startup Klue, a two-year-old startup which uses gesture sensing and other behavioral health metrics to determine when someone is eating. Nothing was disclosed about the terms of the deal, except that Medtronic considers it to be immaterial to 2020 earnings per share. "Bringing Klue and their unique meal detection...
By Dave Muoio 03:23 pm December 16, 2019
Somerville, Massachusetts-based Podimetrics has bumped its $13.4 million Series B funding round up to $16.55 thanks to a new investment from Polaris Partners. The company, which makes a connected platform for diabetic foot ulcer detection, also announced the addition of five new names to advisory board: Dr. Kenneth Kizer, former Veterans Affairs undersecretary for health; Dr. Ronald Geraty, a...
By Dave Muoio 03:48 pm December 10, 2019
Sanofi announced a major strategy shift today that will end the pharma’s diabetes and cardiovascular R&D efforts in favor of a reinvigorated focus on growing its immunology and vaccine businesses. Among the fallout of this new game plan is Onduo, the pharma’s diabetes management joint venture with Verily that the two companies invested $500 million into back in 2016, according to the company’...
By Dave Muoio 10:52 am December 3, 2019
Dexcom continuous glucose monitor users and their caregivers found themselves in the dark this weekend when a key monitoring feature ceased to function with little to no warning. The feature, called Dexcom Follow, transmits an alert when a CGM user’s blood sugar reaches a dangerous level and is often used by parents monitoring their children’s condition. When unexpected issues brought down the...
By Dave Muoio 03:12 pm November 21, 2019
Welldoc is tapping Astellas Pharma to assist Japanese and Asian commercialization efforts for the former’s digital therapeutic for patients with diabetes, the companies announced yesterday. To kick off the deal, Astellas is making an upfront $15 million payment to Welldoc, which will allow the pharma to jointly develop and commercialize the BlueStar product in the region. The two will also be...